AstraZeneca Is Moving the Needle

This drugmaker is making a historic upside breakout. Let's check the charts.

Biogen's Japanese Partner on Alzheimer's Drug Set for Gains

Eisai is working on another promising drug candidate to combat Alzheimer's disease, and will benefit from a split of the profits for Aduhelm.

Moderna's Charts Are Bullish and Pointed Higher

Here's the area where I would like to go long MRNA.

Is It Too Late to Buy Progyny?

A Real Money subscriber asks. We answer.

As America Grows Older, So Does the Appeal of This Dividend REIT

Omega Healthcare offers a 7% yield and promise of growth.

An Updated Technical Strategy for HCA Healthcare

Let's review the charts and indicators.

Jim Cramer: Google's Healthcare Deal With HCA Is Huge

The great thing about Google? Unlike IBM? It isn't trumpeting anything. It's just talking about algorithms, let the eyes glaze over.

Anthem's Charts Look Pretty Healthy

We are again recommending the long side of ANTM, and here are some prices to watch.

Centene Finally Looks Ready to Make a Move Higher

Let's review the charts and indicators.

We Have New Price Targets on Bullish-Looking AbbVie

The charts and indicators of ABBV are pointed higher.